STSP-0902

· Staidson (Beijing) Biopharmaceuticals Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for STSP-0902, covering 2025-05-11 to 2025-09-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Multiple Dose of STSP-0902 in Healthy Subjects [Phase 1]